BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38104118)

  • 1. Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice.
    Rios LE; Lokugamage N; Choudhuri S; Chowdhury IH; Garg NJ
    NPJ Vaccines; 2023 Dec; 8(1):188. PubMed ID: 38104118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
    Chowdhury IH; Lokugamage N; Garg NJ
    Front Immunol; 2020; 11():595039. PubMed ID: 33414785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of
    Lokugamage N; Choudhuri S; Davies C; Chowdhury IH; Garg NJ
    Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32098116
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
    Front Immunol; 2019; 10():1456. PubMed ID: 31293599
    [No Abstract]   [Full Text] [Related]  

  • 5. A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    PLoS Pathog; 2015 May; 11(5):e1004828. PubMed ID: 25951312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice.
    Gupta S; Garg NJ
    PLoS One; 2013; 8(3):e59434. PubMed ID: 23555672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
    Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
    Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
    Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
    Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
    PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the adaptive immune response in murine Trypanosoma cruzi infection influenced by zinc supplementation?
    da Costa CMB; Del Vecchio Filipin M; Santello FH; Pereira LM; Toldo MPA; do Prado Júnior JC; Abrahão AAC
    Eur J Pharm Sci; 2018 Jan; 111():330-336. PubMed ID: 29032059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative and histological assessment of maternal-fetal transmission of Trypanosoma cruzi in guinea pigs: An experimental model of congenital Chagas disease.
    Torres-Vargas J; Jiménez-Coello M; Guzmán-Marín E; Acosta-Viana KY; Yadon ZE; Gutiérrez-Blanco E; Guillermo-Cordero JL; Garg NJ; Ortega-Pacheco A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006222. PubMed ID: 29364882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
    Bhatia V; Garg NJ
    Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease.
    Lokugamage N; Chowdhury IH; Biediger RJ; Market RV; Khounlo S; Warier ND; Hwang SA; Actor JK; Woodside DG; Marathi U; Vanderslice P; Garg NJ
    NPJ Vaccines; 2021 Sep; 6(1):114. PubMed ID: 34497271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
    de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against
    Gamba JC; Roldán C; Prochetto E; Lupi G; Bontempi I; Poncini CV; Vermeulen M; Pérez AR; Marcipar I; Cabrera G
    Front Cell Infect Microbiol; 2021; 11():671104. PubMed ID: 34295832
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregnancy does not deter the development of a potent maternal protective CD8+ T-cell acquired immune response against Listeria monocytogenes despite preferential placental colonization.
    Krishnan L; Pejcic-Karapetrovic B; Gurnani K; Zafer A; Sad S
    Am J Reprod Immunol; 2010 Jan; 63(1):54-65. PubMed ID: 19912156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.
    Cardillo F; Postol E; Nihei J; Aroeira LS; Nomizo A; Mengel J
    Immunology; 2007 Dec; 122(4):584-95. PubMed ID: 17635611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.